This company has been marked as potentially delisted and may not be actively trading. NASDAQ:FWP Forward Pharma A/S (FWP) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Forward Pharma A/S Stock (NASDAQ:FWP) 30 days 90 days 365 days Advanced Chart Get Forward Pharma A/S alerts:Sign Up Key Stats Today's Range$1.95▼$1.9550-Day Range$1.79▼$3.1952-Week Range$1.50▼$6.48VolumeN/AAverage Volume7,484 shsMarket Capitalization$13.83 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark. Read More Receive FWP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Forward Pharma A/S and its competitors with MarketBeat's FREE daily newsletter. Email Address FWP Stock News HeadlinesInside Forward's failed attempt to revolutionize the doctor's officeNovember 14, 2024 | businessinsider.comU.S. Drugmakers Are Breaking Up With Their Chinese Supply-Chain PartnersOctober 31, 2024 | msn.comThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profitable trends in tech … well ahead of Wall Street. Like when he called Nvidia at a mere 80 cents a share. Or Bitcoin when it was trading for just $300. Throughout his illustrious career … Michael has given his followers almost 150 different chances to register triple-digit gains. | Weiss Ratings (Ad)Sangamo: Fabry Disease Gene Therapy Moves Forward With Positive FDA Regulatory DevelopmentOctober 23, 2024 | seekingalpha.comWhy developers are turning to Forward Factory’s Code-to-Earn model (And why you should too)October 23, 2024 | msn.comFinland's largest energy company files €800 million lawsuit against RussiaOctober 22, 2024 | msn.comFirebrick Pharma’s Strategic Moves Boost Market PositionOctober 22, 2024 | markets.businessinsider.comThis Podiatrist Closed The $30 Million Gap Between Orthopedic And Fashion-Forward FootwearOctober 22, 2024 | forbes.comSee More Headlines FWP Stock Analysis - Frequently Asked Questions How were Forward Pharma A/S's earnings last quarter? Forward Pharma A/S (NASDAQ:FWP) issued its earnings results on Thursday, September, 1st. The biotechnology company reported ($0.32) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.26) by $0.06. What other stocks do shareholders of Forward Pharma A/S own? Based on aggregate information from My MarketBeat watchlists, some other companies that Forward Pharma A/S investors own include Gilead Sciences (GILD), SCYNEXIS (SCYX), Sorrento Therapeutics (SRNE), AbbVie (ABBV), Akari Therapeutics (AKTX), Aldeyra Therapeutics (ALDX) and Inovio Pharmaceuticals (INO). Company Calendar Last Earnings9/01/2016Today8/05/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:FWP CIK1604924 Webwww.forward-pharma.com Phone(453) 344-4242FaxN/AEmployees4Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio18.43 Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$10.09 per share Price / Book0.19Miscellaneous Outstanding Shares7,091,000Free Float2,023,000Market Cap$13.83 million OptionableNot Optionable Beta1.38 Social Links The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NASDAQ:FWP) was last updated on 8/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredAltucher: $900 to $108,000? Trump’s “Great Gain” Is HereJames Altucher says two recent events could trigger a historic wealth shift—one driven by a radical Trump poli...Paradigm Press | SponsoredStrange twist to Bitcoin’s rallyThe #1 crypto to buy today Better than Bitcoin? (top crypto for less than $1) Over the past 15 years, B...Stansberry Research | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Forward Pharma A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Forward Pharma A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
